First‐pass Metabolism of 5‐Fluorouracil in Rats

The first‐pass metabolism of 5‐fluorouracil has been investigated in rats to compare systemic bioavailability after administration by different routes, the bioavailability after intravenous bolus administration being defined as unity.

[1]  F. D. Boudinot,et al.  Nonlinear pharmacokinetics of 5-fluorouracil in rats. , 1997, Journal of pharmaceutical sciences.

[2]  H. Yuasa,et al.  Comparative Assessment of D‐Xylose Absorption between Small Intestine and Large Intestine , 1997, The Journal of pharmacy and pharmacology.

[3]  E. Suzuki,et al.  Dose-dependent gastrointestinal absorption of 5-fluorouracil in rats in vivo. , 1996, Biological & pharmaceutical bulletin.

[4]  K. Okuno,et al.  Hepatic extraction ratio of 5-fluorouracil in rats: Dose dependence and effect of uracil and interleukin-2 , 1996 .

[5]  S. Fukushima,et al.  Modulation of the pharmacokinetics of 5'-deoxy-5-fluorouridine and 5-fluorouracil in rats by oral co-administration of acyclothymidine. , 1996, Biological & pharmaceutical bulletin.

[6]  H. Yuasa,et al.  Intestinal brush border transport mechanism of 5-fluorouracil in rats. , 1996, Biological & pharmaceutical bulletin.

[7]  H. Yuasa,et al.  Influence of anesthetic regimens on the intestinal absorption of 5-fluorouracil in rats. , 1995, Biological & pharmaceutical bulletin.

[8]  H. Yuasa,et al.  Effect of dosing volume on gastrointestinal absorption in rats: analysis of the gastrointestinal disposition of L-glucose and estimation of in vivo intestinal membrane permeability. , 1995, Journal of pharmaceutical sciences.

[9]  J. Kneer,et al.  Bioavailability and feasibility of subcutaneous 5-fluorouracil. , 1993, British Journal of Cancer.

[10]  V. H. Lee,et al.  Penetration of 5-fluorouracil and prodrugs across the intestine of the albino rabbit: Evidence for shift in absorption site from the upper to the lower region of the gastrointestinal tract by prodrugs , 1990 .

[11]  Robert B. Diasio,et al.  Clinical Pharmacology of 5-Fluorouracil , 1989, Clinical pharmacokinetics.

[12]  F N Naguib,et al.  Enzymes of uracil catabolism in normal and neoplastic human tissues. , 1985, Cancer research.

[13]  Y. Hayashi,et al.  Salivary excretion of 5-fluorouracil. I. Fluctuation of the saliva/plasma concentration ratio and salivary clearance in beagle dogs following bolus intravenous administration. , 1985, Chemical & pharmaceutical bulletin.

[14]  A. Howell,et al.  Pharmacokinetics of oral and intravenous fluorouracil in humans. , 1980, Journal of pharmaceutical sciences.

[15]  O. Drummer,et al.  Fluorouracil Therapy in Patients with Carcinoma of the Large Bowel: A Pharmacokinetic Comparison of Various Rates and Routes of Administration , 1978, Clinical pharmacokinetics.

[16]  H. Morris,et al.  Dihydrouracil dehydrogenase activity in normal, differentiating and regnerating liver and in hepatomas. , 1971, Cancer research.

[17]  L. Tétreault,et al.  [Clinical pharmacology]. , 1968, Therapie.